1/160
Hi. I made this to help me study. If it helped you, give it a rating! Happy studying!
Biology
Microbiology
GVSU
BMS212
biomedical science
212
Module 4: Control, Antibiotics, Humans, & Microbes
Online
Chapter 13
antimicrobials
fundamentals of antimicrobial chemotherapy
mechanisms of antibacterial drugs
other mechanisms of antibacterial drugs
drug resistance
study
homework
micro
bio
University/Undergrad
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
bacteriostatic drugs
cause a reversable inhibition of growth, with bacterial growth restarting after elimination of the drug
bactericidal
kill the target bacteria; essential of the successful treatment of infections in immunocompromised patients
diversity of targeted bacteria
the spectrum of activity of an antibacterial drug relates to what?
narrow-spectrum antimicrobial
targets only specific subsets of bacterial pathogens (ex. only gram-positive bacteria or only gram-negative bacteria); if the pathogen has been identified, it is best to use this and minimize collateral damage to the normal microbiota
broad-spectrum antimicrobial
targets a wide variety of bacterial pathogens (including gram+ and gram- species) and is frequently used as empiric therapy to cover a wide range of potential pathogens while waiting on lab identification of the pathogen
used for polymicrobic infections
may be selected to treat an infection when a narrow spectrum drug fails bc of development of drug resistance by the target pathogen
superinfection
a secondary infection in a patient having a preexisting infection
develops when the antibacterial intended for the first infection kills the protective microbiota and allows another pathogen resistant to the antibacterial to proliferate and cause a secondary infection
common examples of superinfections
yeast infections (candidiasis) and pseudomembranous colitis caused by Clostridium difficile
dosage
the amount of medication given during a certain time interval
determined to ensure optimum therapeutic drug levels without causing significant toxicity
toxicity
side effects
factors to consider when determining dosage
mass and how drugs are metabolized
half life
rate at which 50% of a drug is eliminated from the plasma
dose dependent drugs
more effective when administered in large doses to provide high levels for a short amount of time
time dependent drugs
more effective when lower optimum levels are maintained over a longer period of time
route of administration
the method used to introduce a drug into the body
niclosamide
treats for tapeworms
colistin
decontaminates the bowels
bacitracin, polymyxin, several antifungals
not easily absorbed by the GI tract so they are applied as topical preps
parenteral route
intravenous or intramuscular injection
preferred and typically performed in health-care settings
synergistic interaction
when two antibacterial drugs are administered together that is better than the efficacy of either drug alone
trimethoprim and sulfamethoxazole (bactrim)
when used alone, only provides a bacteriostatic effect, but when used together are bactericidal
antagonistic interactions
when two drugs combine and produce harmful effects
can cause loss of drug activity, decreased therapeutic levels, or increased toxicity
the issue with TB
it is becoming drug-resistant
problem with antibiotics
they are demanding them for diseased that do not require them and people are becoming more resistant to them
directly observed therapy (DOT)
the supervised administration of medications to patients
selective toxicity
selectively kills or inhibits the growth of microbial targets while causing minimal or no harm to the host
antimicrobial drugs
are what they are because the prokaryotic cells provides a greater variety of unique targets for selective toxicity
mode of action
the when in which the drug affects microbes at the cellular level
mode of action: inhibit cell wall biosynthesis
target: penicillin-binding proteins, peptidoglycan subunits, peptidoglycan subunit transport
mode of action: inhibit biosynthesis of proteins
target: 30S ribosomal subunit, 50S ribosomal subunit
mode of action: disrupt membranes
target: lipopolysaccharide (inner and outer membranes)
mode of action: inhibit nucleic acid synthesis
target: RNA, DNA
mode of action: antimetabolites
target: folic acid synthesis enzyme, mycolic acid synthesis enzyme
mode of action: mycobacterial adenosine triphosphate (ATP) inhibitor
target: mycobacterial ATP synthase
target: penicillin-binding proteins
drug class: (beta)-lactams: penicillins, cephalosporins, monobactams, carbapenems
target: peptidoglycan subunits
drug class: glycopeptides
target: peptidoglycan subunit transport
drug class: bacitracin
target: 30S ribosomal subunit
drug class: aminoglycosides, tetracyclines
target: 50S ribosomal subunit
drug class: macrolides, lincosamides, chloramphenicol, oxazolidinones
target: lipopolysaccharide (inner and outer membranes)
drug class: polymyxin B, colistin, daptomycin
target: RNA
drug class: rifamycin
target: DNA
drug class: fluoroquinolones
target: folic acid synthesis enzyme
drug class: sulfonamides, trimethoprim
target: mycolic acid synthesis enzyme
drug class: isonicotinic acid hydrazide
target: mycobacterial ATP synthase
diarylquinoline
osmotic lysis
what becomes more susceptible when antibacterials block steps in the biosynthesis of peptidoglycan
β-lactams
characterized by the presence of a β-lactam ring found within the central structure of the drug molecule
β-lactam antibacterials
block the crosslinking of peptide chains during the the biosynthesis of new peptidoglycan in the bacterial cell walls; able to block because the structure is similar to the structure of the peptidoglycan subunit that is recognized by the crosslinking enzyme
transpeptidase (penicillin-binding protein)
crosslinking enzyme that recognizes the β-lactam structure
semisynthetic β-lactam drugs
have been developed with changes to he R groups to have increased potency, spectrum of activity, longer half lives, etc
penicillin G and penicillin V
natural antibiotics from fungi and are primarily active against gram+ bacterial pathogens, and a few gram- bacterial pathogens like Pasteurella multocida
aminopenicillins
i.e., ampicillin and amoxicillin
are made by adding an amino group (-NH2) to penicillin G
increased spectrum of activity against more gram- pathogens
hydroxyl group (-OH)
added to amoxicillin to increase acid stability which allows for improved oral consumption
methicillin
a semisynthetic penicillin that was developed to address the spread of penicillinases
made from a change in the r-group of penicillin G to the more bulky dimethoxyphenyl group, which provided protection of the β-lactam ring
first penicillinase-resistant penicillin
Penicillinases
enzymes produced by some bacteria that can break down penicillin, making the antibiotic ineffective
cephalosporins
contain a β-lactam ring fused to a six-member ring rather than the five-member ring found in penicillins
block the transpeptidase activity of penicillin-binding proteins
have an increased resistance to enzymatic inactivation by β-lactamases
cephalosporin C
originally isolated from the fungus Cephalosporium acremonium
similar spectrum of activity to penicillin against gram+ and increased activity against gram-
posesses 2 R groups which allows for greater diversity
r group
a placeholder for any group of atoms attached to a molecule
semisynthetic cephalosporins
large family; labeled by generation
one of the 5th gen has been developed to be active against methicillin resistant Staphylococcus aureus (MRSA)
carbapenems and monobactams
have a β-lactam ring and inhibit the transpeptidase activity of penicillin-binding proteins
aztreonam
only monobactam used clinically
imipenem, meropenem, doripenem
semisynthetic drugs from the carbapenem family
provide a very broad-spectrum activity against gram+ and gram- bact. pathogens
vancomycin
member of the glycopeptides
a natural antibiotic from the actinomycete Amycolatopsis orientalis
inhibits cell wall biosynthesis andis bactericidal
does not directly inactivate penicillin-binding proteins, instead creates a strucural blockage on the end of the peptide chain of cell wall precursors that stops the cell wall subunits from being incorporated in transglycosylation
also blocks transpeptidation
bactericidal against gram-positive bacterial pathogens, but it is not active against gram-negative
transglycosylation
a process in bacteria where sugar molecules (specifically N-acetylglucosamine and N-acetylmuramic acid) are linked together to form a long chain
bacitracin
a group of structurally similar peptide antibiotics originally isolated from Bacillus subtilis
blocks the cell activity of a specific cell membrane molecule that is responsible for the movement of peptidoglycan precursors, preventing their incorporation into the cell wall
effective against gram+ organisms found on the skin such as Staphylococcus and Streptococcus
can be administered orally or intramuscularly
can be nephrotoxic so it is combined with neomycin and polymyxin in topical ointments like Neosporin
70S cytoplasmic ribosomes
structurally different from the ones in animal cells so they are a selective target for antibacterial drugs
aminoglycosides
large, highly polar antibacterial drugs that bind to the 30S subunit of bacterial ribosomes, impairing the proofreading ability of the ribosomal complex
causes a mismatch between codons and anicodons
streptomycin, gentamicin, neomycin, and kanamycin
aminoglycosides
potent broad spectrum antibacterials
nephrotoxic, neurotoxic, and ototoxic
tetracyclines
bind to the 30S subunit
bacteriostatic
inhibit protein synthesis by blocking the association of tRNAs with the ribosome during translation
broad spectrum
streptomyces
produces tetracyclines
doxycycline and tigecycline
semisynthetic tetracyclines
problems with tetracyclines
phototoxicity, discoloration of developing teeth, liver toxicity
polyketides
naturally produced secondary metabolites
complex compounds produced in a stepwise fashion through the repeated addition of two-carbon units by a mechanism similar to that used for fatty acid synthesis
macrolides
Broad-spectrum, bacteriostatic drugs that block the elongation of proteins by inhibiting peptide bond formation; bind to the 50S subunit
erythromycin
first macrolide
isolated from Streptomyces erythreus
prevents translocation
azithromycin
semisynthetic macrolide
has a broader spectrum of activity, fewer side effects, and significantly longer half life than erythromycin
telithromycin
semisynthetic macrolide
first ketolide
serious hepatotoxicity
lincomycin and semisynthetic clindamycin
lincosamides
similar in mode of action to macrolides
particularly active against streptococcal and staphylococcal infections
chloramphenicol
bind to the 50S subunit
produced by Streptomyces venezuelae
easily synthesized
used to treat a wide range of infections (meningitis, typhoid fever, conjunctivitis)
can cause lethal gray baby syndrome, suppression of bone marrow production and anemia
chloramphenicol anemia
can cause the targeting of mitochondrial ribosome within hematopoietic stem cells or idiosyncratic which involves an irreversible lethal loss of blood cell production known as aplastic anemia
oxazolidinones (inc. linezolid)
broad spectrum synthetic protein synthesis inhibitors
binds to the 50S subunit of gram+ and gram-
interfere with formation of the initiation complex for translation and prevent translocation from A side to P site
metronidazole
semisynthetic member of the nitroimidazole family that is also a antiprotozoan
interferes with DNA replication in target cells
rifamipin
an semisynthetic member of the rifamycin family
functions by blocking RNA polymerase activity in bacteria
hetpatotoxic
what does RNA polymerase enzymes being different in bacteria do?
it allows for selective toxicity against bacterial cells; i.e. tuberculosis
nalidixic acid
a byproduct during the synthesis of chloroquine
selectively inhibits the activity of bacteria DNA gyrase, blocking DNA replication
chloroquine
a antimalarial drug
fluoroquinolones
i.e., ciprofloxacin, levofloxacin
chemically modified versions of the og quinolone backbone
inhibit the activity of DNA gyrase
ciprofloxacin and levofloxacin
effective against a broad spectrum of gram-pos or gram-neg bacteria and treat a wide range of infections (urinary tract, respiratory, abdominal, skin)
side effects include phototoxicity, neurotoxicity, cardiotoxicity, glucose metabolism dysfunction, and increased risk for tendon rupture
antimetabolites
competitive inhibitors for bacterial metabolic enzymes
sulfonamides (sulfa drugs)
oldest synthetic antibacterial agents
structural analogues of para-aminobenzoic acid (PABA)
inhibits the enzyme involved in the production of hydrofolic acid and block the bacterial biosynthesis of folic acids and, subsequently, pyrimidines and purines needed for nucleic acid synthesis
bacteriostatic against gram-pos and neg pathogens
selectively toxic for bacteria but may cause an allergic reaction
para-aminobenzoic acid (PABA)
an early intermediate in folic acid synthesis
sulfones
structurally similar to sulfonamides
used for the treatment of Hansen’s disease (leprosy)
trimethoprim
synthetic antimicrobial compound that serves as an antimetabolite like a sulfonamide but is a structural analogue of dihydrofolic acid and inhibits a later step in the metabolic pathway
used with sulfamethoxazole to treat urinary tract infections, ear infections, and bronchitis
trimethoprim and sulfamethoxazole
used together to treat to treat urinary tract infections, ear infections, and bronchitis
when used together is bactericidal
should be used carefully during pregnancy
isoniazid
antimetabolite with specific toxicity for mycobacteria
used in combo with rifampin or streptomycin to treat TB
administered as a prodrug, requiring activation through the action of an intracellular bacterial peroxidase enzyme, forming isoniazid-NAD and isoniazid-NADP, preventing the synthesis of mycolic acid, which is essential for mycobacterial cell walls
possible side effects are hepatotoxicity, neurotoxicity, and anemia
prodrug
a medication that is not active when you take it. Instead, it becomes active only after your body processes it
bedaquiline
diarylquinoline
inhibits mycobacterial growth through interference with the function of ATP synthases, possibly by interfering with the use of the hydrogen ion gradient for ATP synthesis by oxidative phosphorylation
because of its side effects (hepatotoxicity and potentially lethal heart arrhythmia), it is only used for extreme cases of TB when absolutely needed
disruption of the cell membrane
the most common mode of action for antifungal drugs
antifungal drugs
take advantage of the biochemical pathways that synthesize sterols
sterols
important in maintaining proper membrane fluidity and therefore proper function of the cell membrane
ergosterol
predominant membrane sterol in fungi cell membranes
targeted by antifungal drugs